Subscribe for the Newsletter

Mobile Navigation

On the Future of Ocular Therapies

Roca Therapeutics

Roca Therapeutics

Apr 29, 2021PAO-04-22-R221-63

At a Milano, Italy stop on the Road to 2021 trip, Gilles Pagès, CSO at Roca Therapeutics and Director of Research at INSERM, discusses the future of ocular therapies.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.